Who
Laurent Humeau
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Inovio Pharmaceuticals.
In numbers
- Trades disclosed
- 117
- Buys
- 2
- Sells
- 5
- Bought
- $60K
- Sold
- $1.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Mar 2019
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —6,027 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,6602,163 at $1.23 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,027 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,027 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,160 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,440 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,160 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,440 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —6,027 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,6602,163 at $1.23 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,771 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,2261,712 at $1.30 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,771 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,771 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,771 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,2261,712 at $1.30 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,840 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,560 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,840 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,560 at $0.00 | filing |
News
Critical Analysis: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)INO · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Laurent Humeau; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.